Navigation Links
Other patients bear the real cost of Herceptin

The real cost of Herceptin is borne by other patients whose treatment has to be dropped to balance the books, say doctors in this week’s BMJ.

New guidance from the National Institute for health and Clinical Excellence (NICE) recommends trastuzumab (Herceptin) in early breast cancer, but it provides no extra funding and does not suggest what cuts should be made to release this extra money. This leaves medical staff with difficult decisions to make.

Doctors at the Norfolk and Norwich University Hospital NHS Trust and the University of East Anglia calculated that they will have to find £1.9m each year to make Herceptin available to the patients who may be eligible. This becomes £2.3m if the costs of testing and monitoring patients are added.

But the real cost lies in the services that will be cut to provide this money, they write.

To illustrate this, they audited drug costs in their hospital’s cancer centre and estimated how they could save £1.9m by cutting chemotherapy and palliative care treatments.

The sum of £1.9m would enable us to treat 75 patients with Herceptin, but at four times the cost of the adjuvant treatments, they say. These treatments have been proved to be clinically effective and their estimated cost effectiveness is far greater than that currently expected for Herceptin.

So they could fund Herceptin if they did not treat 355 patients receiving adjuvant treatment (16 of whom would be cured) or 208 patients receiving palliative chemotherapy, and if they found £500,000 from another source.

“These untreated patients will be people we know,?say the authors. “We will be the ones to tell them they are not getting treatment that has been proved to be effective and which costs relatively little, because it is not the treatment of the moment.?

These results are obviously not definitive, but illustrate the fundamental challenge facing the NHS ?the tension between national priority setti
'"/>

Source:BMJ-British Medical Journal


Page: 1 2

Related biology news :

1. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
2. Otherworldly bacteria discovered two miles down
3. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
4. Potential Cure for Lymphoma in HIV patients
5. Ophthalmologists implant five patients with artificial silicon retina microchip
6. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
7. Measuring hormone cuts antibiotic use in half in pneumonia patients
8. Doctors closer to using gene analysis to help trauma patients
9. Research shows smoking adds a decade to reproductive age of IVF patients
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Other patients bear the real cost Herceptin

(Date:6/18/2013)... Ph.D., Medical Research Council, Laboratory of Molecular Biology, ... 2013 ICAAC Young Investigator Award. Torrent is being ... the first algorithm to predict antimicrobial regions in ... "we are now applying this algorithm to interrogate ... peptide leads with very appealing results." , ...
(Date:6/18/2013)... between 5% and 10% of breast and ovarian cancers ... these tumours are attributable to inherited mutations from the ... patients with these mutations, PARP inhibitors, which are currently ... them a new option for personalised cancer treatment, an ... that a fraction of these patients generate resistance to ...
(Date:6/17/2013)... central nervous system infections may well be suffering from ... a study to be published in mBio , ... Microbiology. Researchers have detected the virus in spinal fluid ... system infections of unknown cause, and in an average ... poultry, suggesting animals may serve as reservoirs for transmission ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... Nia, the warm and cold phases in the eastern half ... El Nio events more than several months ahead is now ... world has been hampered by the short instrumental record. An ... resolved tree-ring records from North America, particularly from the US ...
... May 6, 2011 According to the United States Department ... in restaurants. As it is widely known, food prepared ... is often higher in calories, saturated fat, and sodium. ... May/June 2011 issue of the Journal of Nutrition Education ...
... model of AIDS, scientists have identified a vaccine-generated ... by the monkey version of HIV, called simian ... antibodies generated by immunization were associated with protection ... step toward understanding how an effective HIV vaccine ...
Cached Biology News:Tree rings tell a 1,100-year history of El Niño 2Families are 'lovin' it' 2Antibodies help protect monkeys from HIV-like virus, NIH scientists show 2
(Date:6/18/2013)... 18, 2013 In support of Swiss ... Consulate General of Switzerland in New York is pleased ... MS Tûranor PlanetSolar , to Manhattan. PlanetSolar is ... Expedition 2013 tour with scientists on board from the ... d’Aboville, runs exclusively on energy from the sun and ...
(Date:6/18/2013)... Demanding industrial and environmental conditions are no ... and Glass Ball Lenses, now available in an extensive ... , of Philadelphia , PA. , Optical Ball Lenses ... beams without the need for direct physical contact. That’s ... mohs) make it the ideal choice for fiber-optic applications ...
(Date:6/18/2013)... June 18, 2013 Nasseo, Inc. today ... Challenge Winner out of hundreds of applicants by the ... Arizona Innovation Challenge . The Arizona Innovation Challenge ... a technology commercialization challenge, granting a financial award to ... technology ventures. Nasseo’s state of the art dental and ...
(Date:6/18/2013)...  regulated information — Global biopharmaceutical company UCB, Inc. ... the launch of a new Pledge campaign for people ... Pledge empowers the millions of Americans living ... personal commitment to demand more: greater understanding of the ... additional partial-onset seizure control.  More information is available at ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... BETHESDA, Md., June 5, 2011 Northwest Biotherapeutics (OTC.BB: ... a series of financing arrangements, including a $3 million ... million of further funding on fixed, specified and favorable ... the Company chooses.  This series of financing arrangements will ...
... 3, 2011  Grifols, S.A. (NASDAQ: ... biopharmaceutical manufacturer based in Barcelona, Spain today announced ... acquisition of Talecris Biotherapeutics Holdings Corp. ("Talecris").  In ... Grifols non-voting shares that trade in the U.S. ...
... 3, 2011 Masimo (NASDAQ: MASI ) today announced ... & Company 31st Annual Growth Stock Conference at the Four Seasons ... Time.  A live audiocast of the presentation will be available on ... audiocast will be available following the live presentation. ...
Cached Biology Technology:Northwest Biotherapeutics Announces Series of Financing Arrangements 2Northwest Biotherapeutics Announces Series of Financing Arrangements 3Northwest Biotherapeutics Announces Series of Financing Arrangements 4Grifols Announces the Completion of its Acquisition of Talecris and the Listing of its ADSs on NASDAQ 2Masimo to Present at William Blair & Company 31st Annual Growth Stock Conference 2
... UniPrimer-fluorescein is a hairpin primer labeled ... (fluorescein and non-fluorescent quencher) and a ... UniPrimer is identical to the UniPrimer ... System (S7901) and is provided at ...
... Disposable. Virgin, optically clear polystyrene ... and alphanumeric coordinates for cell counting. ... number is a new product number, ... number. If showing no availability yet, ...
... The Rotofor purification system with PowerPac 3000 ... protein separation and purification by liquid-phase isoelectric ... mini (18 ml) and standard (60 ml) ... electrode chambers, PowerPac 3000 power supply, 10 ...
Recognizes Human Connexin 45. Due to sequence homologies, this antibody is also expected to react with canine (100% homology) and mouse (92% homology) Connexin 45. Also confirmed to work on rat C6 c...
Biology Products: